Elbow / Lateral Epicondylitis / Class IV Laser / VAS+PREE

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Laser therapy for Medial Epicondylitis.

The Laser Therapy market was valued at $3.11 Billion in 2023, and is estimated to grow to over $5.5 Billion by 2032. Medial Epicondylitis is the most common condition affecting the elbow and have a global prevalence of 1% to 3%. Manufacturers will thus increasingly spend on obtaining and maintaining regulatory approvals for marketing those products for Medial Epicondylitis. Increasingly, that spend will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Medial Epicondylitis cases, outcomes and other case data.